# FDA 483 - Eagle Labs Inc. - October 31, 2024

Source: https://www.keypedia.com/records/483/eagle-labs-inc/20e3a64d-6c2a-4b3e-8912-5dff74121dc1

> FDA 483 for Eagle Labs Inc. on October 31, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eagle Labs Inc.
- Inspection Date: 2024-10-31
- Product Type: drugs
- Office Name: Florida District Office
- Summary: Eagle Labs Inc. in Seminole, FL, was inspected by the FDA, revealing significant deficiencies in their manufacturing practices for dietary supplements. The inspection found that the firm failed to establish complete product and component specifications, did not use scientifically valid testing methods, and maintained incomplete batch production records. These issues indicate a lack of adequate quality control and documentation for their dietary supplement products.

## Related Documents

- [483 - 2023-12-06](https://www.keypedia.com/records/483/eagle-labs-inc/415d0084-2686-40df-bf42-3b8078844d55)

## Related Officers

- [investigator](https://www.keypedia.com/people/narahi-j-alvarez-alcazar/5441f0c2-d2bd-40e3-afaf-c9ced6042164)

Company: https://www.keypedia.com/companies/eagle-labs-inc/e0addf0e-7d1b-4221-940b-18435b523a6f

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9